Envision Pharma Group Acquires OKRA.ai

Ankura Acquires Omniscient Platforms and Omniscient Health

November 19, 2025

Data & Analytics

Ankura Consulting Group, LLC has acquired Omniscient Platforms and its subsidiary Omniscient Health to bolster Ankura's digital transformation, data and AI advisory, and technology capabilities. The acquisition also strengthens Ankura's footprint in Latin America.

Databricks Acquires Okera

May 3, 2023

Data & Analytics

Databricks announced it will acquire San Francisco-based Okera, a startup that builds no-code, AI-powered data governance tools for managing sensitive and personally identifiable data. Financial terms were not disclosed; the deal is expected to close later this month. Okera was last valued at $100 million in 2021 and had raised nearly $40 million, the company confirmed.

Envision Pharma Group Acquires doDOC

March 22, 2021

Software

Envision Pharma Group, a portfolio company of GHO Capital Partners, has acquired doDOC Corp., a Boston-founded SaaS platform for collaborative document review and authoring tailored to the life sciences. doDOC will operate as a business unit under its existing brand and be integrated into Envision's iEnvision medical affairs platform to expand document collaboration capabilities and improve workflow efficiency.

Envision Pharma Group Acquires Two Labs

November 12, 2020

Healthcare Services

Envision Pharma Group has acquired Two Labs, a Powell, Ohio-based provider of pharmaceutical commercialization, launch planning, market access and market intelligence services. The deal, which follows increased investment in Envision from GHO Capital, strengthens Envision's US presence and expands its launch-excellence capabilities; Excellere Partners will exit its investment in Two Labs.

GHO Capital Leads Consortium to Acquire Majority Stake in Envision Pharma Group from Ardian

November 5, 2020

Healthcare Services

GHO Capital Partners, leading a consortium that includes Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, together with Envision management and employees, has acquired a majority stake in Envision Pharma Group as Ardian exits its investment. The transaction will support Envision's continued growth, wider rollout of its iEnvision medical affairs platform and strategic acquisitions to expand its medical affairs, communications and technology capabilities.

Envision Pharma Group Acquires 90TEN

April 8, 2020

Healthcare Services

Envision Pharma Group, a portfolio company backed by Ardian and GHO Capital, has acquired London-based healthcare communications consultancy 90TEN. 90TEN will retain its brand and management, bringing behavioral science-led communications capabilities to Envision's global medical affairs and communications offerings.